ARCHIVES

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

ODAC Discussion: NCI’s Richard Simon Cautions About Rules Of Thumb

January 30, 2009

In Brief: Wells Tapped For GM Cancer Foundation; Calder Named NABCO Associate Director

January 17, 1997

ACS-Led National Cancer Dialogue Beset By Patient Mistrust, Lack Of Openness

January 21, 2000

Summit Tells Women To Get A Mammogram, Encourages Others, Too

September 29, 1989

NCCS Networker Volume 9 Issue 2, Summer 1995

June 13, 1995

SAIC Frederick Offers Use Of Drug Facility

August 4, 1995